Selected article for: "coronavirus disease and vaccine drug"
Author: Liu, Xue; Liu, Chao; Liu, Gang; Luo, Wenxin; Xia, Ningshao
Title: COVID-19: Progress in diagnostics, therapy and vaccination
  • Cord-id: q7d0ysbo
  • Document date: 2020_6_19
    • ID: q7d0ysbo
    Snippet: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs h
    Document: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.

    Search related documents:
    Co phrase search for related documents
    • abnormal ct imaging and acid detection: 1
    • abnormal ct imaging and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • abnormal ct imaging and lopinavir ritonavir: 1
    • abnormal ct imaging and lopinavir ritonavir treatment: 1
    • abnormal ct imaging and lung damage: 1
    • acceptable safety profile and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acceptable safety profile and additional safety: 1
    • acceptable safety profile and live virus: 1
    • acceptable safety profile and lopinavir ritonavir: 1